Cresco Labs (Germany) Today
| 6CQ Stock | EUR 0.70 0.05 6.67% |
PerformanceVery Weak
| Odds Of DistressQuite High
|
Cresco Labs is trading at 0.7 as of the 11th of March 2025. This is a 6.67 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.7. Cresco Labs has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 10th of January 2025 and ending today, the 11th of March 2025. Click here to learn more.
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It owns and operates 32 dispensaries, as well as 44 retail licenses. CRESCO LABS operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. The company has 280.99 M outstanding shares. More on Cresco Labs
Moving together with Cresco Stock
Moving against Cresco Stock
Cresco Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cresco Labs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cresco Labs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Charles Bachtell |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Cresco Labs (6CQ) is traded on Frankfurt Exchange in Germany and employs 3,300 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 518.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cresco Labs's market, we take the total number of its shares issued and multiply it by Cresco Labs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cresco Labs classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 280.99 M outstanding shares.
Cresco Labs has accumulated about 131.04 M in cash with 14.49 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4.
Check Cresco Labs Probability Of Bankruptcy
Ownership AllocationCresco Labs holds a total of 280.99 Million outstanding shares. Cresco Labs retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cresco Ownership Details
Cresco Labs Risk Profiles
Although Cresco Labs' alpha and beta are two of the key measurements used to evaluate Cresco Labs' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.12 | |||
| Standard Deviation | 5.19 | |||
| Variance | 26.97 | |||
| Risk Adjusted Performance | (0.09) |
Cresco Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cresco Labs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Cresco Labs Corporate Directors
| Gerald Corcoran | Independent Director | Profile | |
| Randy Podolsky | Independent Director | Profile | |
| Robert Sampson | Independent Director | Profile | |
| Brian McCormack | Independent Director | Profile |
Other Information on Investing in Cresco Stock
Cresco Labs financial ratios help investors to determine whether Cresco Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cresco with respect to the benefits of owning Cresco Labs security.